AcuCort AB (ACUC.ST)

SEK 0.75

(-3.1%)

Total Assets Summary of AcuCort AB

  • AcuCort AB's latest annual total assets in 2023 was 58.5 Million SEK , up 17.71% from previous year.
  • AcuCort AB's latest quarterly total assets in 2024 Q2 was 53.87 Million SEK , up 14.49% from previous quarter.
  • AcuCort AB reported annual total assets of 49.7 Million SEK in 2022, down -21.35% from previous year.
  • AcuCort AB reported annual total assets of 63.19 Million SEK in 2021, up 33.61% from previous year.
  • AcuCort AB reported quarterly total assets of 47.05 Million SEK for 2024 Q1, down -19.57% from previous quarter.
  • AcuCort AB reported quarterly total assets of 43.75 Million SEK for 2023 Q3, up 6.51% from previous quarter.

Annual Total Assets Chart of AcuCort AB (2023 - 2016)

Historical Annual Total Assets of AcuCort AB (2023 - 2016)

Year Total Assets Total Assets Growth
2023 58.5 Million SEK 17.71%
2022 49.7 Million SEK -21.35%
2021 63.19 Million SEK 33.61%
2020 47.29 Million SEK -15.51%
2019 55.98 Million SEK 105.09%
2018 27.29 Million SEK -13.32%
2017 31.49 Million SEK 30.26%
2016 24.17 Million SEK 0.0%

Peer Total Assets Comparison of AcuCort AB

Name Total Assets Total Assets Difference
AlzeCure Pharma AB (publ) 32 Million SEK -82.829%
BioGaia AB (publ) 2.33 Billion SEK 97.492%
Enzymatica AB (publ) 125.91 Million SEK 53.533%
Enorama Pharma AB (publ) 34.38 Million SEK -70.153%
Gabather AB (publ) 2.93 Million SEK -1892.067%
Klaria Pharma Holding AB (publ.) 73.12 Million SEK 19.985%
Moberg Pharma AB (publ) 634.73 Million SEK 90.782%
Nanexa AB (publ) 132.25 Million SEK 55.763%
Newbury Pharmaceuticals AB (publ) 90.87 Million SEK 35.615%
ODI Pharma AB 12.27 Million SEK -376.636%
Orexo AB (publ) 786.6 Million SEK 92.562%
Probi AB (publ) 1.55 Billion SEK 96.226%
Swedencare AB (publ) 9.52 Billion SEK 99.386%
Swedish Orphan Biovitrum AB (publ) 74.02 Billion SEK 99.921%
Toleranzia AB 160.42 Million SEK 63.53%
Vivesto AB 355.87 Million SEK 83.56%